RAB8A Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-RAB8A antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | RAB8A |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human |
| Isotype | n/a |
| Format | peptide affinity purified |
| Size | 0.08 mL, 0.4 mL |
| Concentration | vial concentration: 0.5 |
| Applications | Western Blot (WB), ELISA (EIA), Immunohistochemistry (IHC), Flow Cytometry (FC/FACS) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | This RAB8A antibody is generated from rabbits immunized with human RAB8A recombinant protein. The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. Anessential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. RAB8A is a member of the peptidase T1A family, that is a 20S core alpha subunit. A pseudogene has been identifie |
| Immunogen | n/a |
| Other Names | [Ras-related protein Rab-8A; Oncogene c-mel; RAB8A; MEL; RAB8] |
| Gene, Accession # | [RAB8A], Gene ID: 4218, NCBI: NP_005361.2, UniProt: P61006 |
| Catalog # | MBS9211860 |
| Price | $165, $370 |
| Order / More Info | RAB8A Antibody from MYBIOSOURCE INC. |
| Product Specific References | Kato,S., et.al., Gene 150 (2), 243-250 (1994) Bey,F., et.al., Mol. Gen. Genet. 237 (1-2), 193-205 (1993) |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies